Skip to main content
. 2022 Aug 21;22:690. doi: 10.1186/s12877-022-03382-z

Table 1.

Baseline characteristics of the included participants according to the level of FPG

Total NFG IFG T2DM
Variable N = 59,874 N = 49,057 (81.9) N = 5898 (9.9) N = 4919 (8.2) P values
Age, years 65 (62–72) 65 (62–72) 65 (62–72) 66 (62–72) 0.001
SBP, mmHg 130 (120–145) 130 (120–142) 135 (121–150) 138 (125–150)  < 0.001
TG, mmol/L 1.26 (0.92–1.63) 1.23 (0.90–1.60) 1.34 (1.00–1.83) 1.48 (1.09–2.13)  < 0.001
TC, mmol/L 4.76 (4.18–5.36) 4.71 (4.16–5.31) 4.86 (4.23–5.53) 4.97 (4.31–5.62)  < 0.001
BMI, kg/m2 23.94 (22.09–26.35) 23.81 (21.99–26.08) 24.73 (22.76–27.21) 25.11 (22.99–27.55)  < 0.001
Sex  < 0.001
 Male 28,367 (47.4) 23,654 (48.2) 2587 (43.9) 2126 (43.2)
 Female 31,507 (52.6) 25,403 (51.8) 3311 (56.1) 2793 (56.8)
Smoking  < 0.001
 Never 51,437 (85.9) 41,973 (85.6) 5155 (87.4) 4309 (87.6)
 Former 1300 (2.2) 1043 (2.1) 142 (2.4) 115 (2.3)
 Current 7137 (11.9) 6041 (12.3) 601 (10.2) 495 (10.1)
Alcohol consumption 0.001
 Never 55,915 (93.4) 45,863 (93.5) 5506 (93.4) 4546 (92.4)
 Once in a while 2365 (3.9) 1938 (4.0) 218 (3.7) 209 (4.2)
 More than once a week 504 (0.8) 416 (0.8) 50 (0.8) 38 (0.8)
 Every day 1090 (1.8) 840 (1.7) 124 (2.1) 126 (2.6)
Physical exercise  < 0.001
 Never 45,161 (75.4) 37,447 (76.3) 4246 (72.0) 3468 (70.5)
 Once in a while 3008 (5.0) 2514 (5.1) 265 (4.5) 229 (4.7)
 More than once a week 2013 (3.4) 1647 (3.4) 200 (3.4) 166 (3.4)
 Every day 9692 (16.2) 7449 (15.2) 1187 (20.1) 1056 (21.5)
BMI (kg/m2) categories  < 0.001
 BMI < 18.5 1288 (2.2) 1152 (2.3) 91 (1.5) 45 (0.9)
 18.5 ≤ BMI < 24 28,982 (48.4) 24,798 (50.5) 2390 (40.5) 1794 (36.5)
 24 ≤ BMI < 28 21,615 (36.1) 17,261 (35.2) 2305 (39.1) 2049 (41.7)
 BMI ≥ 28 7989 (13.3) 5846 (11.9) 1112(18.9) 1031 (21.0)
Self-reported comorbidity  < 0.001
 CHD, COPD, cancer, stroke 14,888 (24.9) 11,830 (24.1) 1597 (27.1) 1461 (29.7)
Death 7928 (13.2) 6457 (13.2) 712 (12.1) 759 (15.4)  < 0.001

SBP Systolic blood pressure, CHD Coronary heart disease, COPD Chronic obstructive pulmonary disease